Survival of skin cancer stem cells requires the Ezh2 polycomb group protein
Open Access
- 12 May 2015
- journal article
- research article
- Published by Oxford University Press (OUP) in Carcinogenesis
- Vol. 36 (7) , 800-810
Abstract
Polycomb group proteins, including Ezh2, are important candidate stem cell maintenance proteins in epidermal squamous cell carcinoma. We previously showed that epidermal cancer stem cells (ECS cells) represent a minority of cells in tumors, are highly enriched in Ezh2 and drive aggressive tumor formation. We now show that Ezh2 is required for ECS cell survival, migration, invasion and tumor formation and that this is associated with increased histone H3 trimethylation on lysine 27, a mark of Ezh2 action. We also show that Ezh2 knockdown or treatment with Ezh2 inhibitors, GSK126 or EPZ-6438, reduces Ezh2 level and activity, leading to reduced ECS cell spheroid formation, migration, invasion and tumor growth. These studies indicate that epidermal squamous cell carcinoma cells contain a subpopulation of cancer stem (tumor-initiating) cells that are enriched in Ezh2, that Ezh2 is required for optimal ECS cell survival and tumor formation and that treatment with Ezh2 inhibitors may be a strategy for reducing ECS cell survival and suppressing tumor formation.Keywords
This publication has 65 references indexed in Scilit:
- Durable tumor regression in genetically altered malignant rhabdoid tumors by inhibition of methyltransferase EZH2Proceedings of the National Academy of Sciences of the United States of America, 2013
- Identification and Characterization of Tumor-Initiating Cells in Human Primary Cutaneous Squamous Cell CarcinomaJournal of Investigative Dermatology, 2012
- A Humanized Stromal Bed Is Required for Engraftment of Isolated Human Primary Squamous Cell Carcinoma Cells in Immunocompromised MiceJournal of Investigative Dermatology, 2012
- The role of EZH2 in tumour progressionBritish Journal of Cancer, 2011
- Polycomb Group Proteins Are Key Regulators of Keratinocyte FunctionJournal of Investigative Dermatology, 2011
- Expression of Bmi-1 in Epidermis Enhances Cell Survival by Altering Cell Cycle Regulatory Protein Expression and Inhibiting ApoptosisJournal of Investigative Dermatology, 2008
- ALDH1 Is a Marker of Normal and Malignant Human Mammary Stem Cells and a Predictor of Poor Clinical OutcomeCell Stem Cell, 2007
- Identification of a subpopulation of cells with cancer stem cell properties in head and neck squamous cell carcinomaProceedings of the National Academy of Sciences, 2007
- Self-renewal and solid tumor stem cellsOncogene, 2004
- Prospective identification of tumorigenic breast cancer cellsProceedings of the National Academy of Sciences of the United States of America, 2003